What is Seaport Therapeutics 's EBITDA?

Seaport Therapeutics (SPTX) reported EBITDA of -$27.52M in Q1 2026.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Seaport Therapeutics SPTX EBITDA

EBITDA at other companies

ConstelliumCSTM

$384M+127%

Power IntegrationsPOWI

$8.02M-43.4%

Liberty EnergyLBRT

$136.34M-6.6%

Ryan Specialty HoldingsRYAN

$98.66M-4.1%

MDU Resources GroupMDU

$169.88M+3.5%

Remitly Global, Inc.RELY

$59.94M+240%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Calculated from Seaport Therapeutics ’s reported figures.

−$27.5Moperating income+$26.0Kdepreciation and amortization cf=-$27.52M

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's EBITDA?: Seaport Therapeutics (SPTX) reported EBITDA of -$27.52M in Q1 2026.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.